Kari Wisinski
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers (NCT03911973) | Kari Wisinski | 2019-04-17 |
| Ribociclib and Bicalutamide in AR+ TNBC (NCT03090165) | Kari Wisinski | 2018-05-07 |
Track Kari Wisinski automatically
Every clearance here is in the API, with alerts when new ones post.